|
Vertec and Optasia Medical |
 |
 |
 |
|
Vertec Scientific are pleased to announce their partnering with Optasia Medical to enhance the use of data from the Hologic range of DXA scanners and Swissray digital x-ray systems marketed by Vertec. Comprising a user-friendly software suite, SpineAnalyzer can be resident on a PACS client workstation for all to access or any laptop or desktop Windows PC.SpineAnalyzer aids the clinician in the vertebral assessment workflow of lateral spine X-rays or DXA/VFA (Vertebral Fracture Assessment) T4-L4 images from patients at risk of, or suffering from, osteoporosis. It does this by facilitating the organisation and viewing of these images in DICOM or TIFF format from PACS, DICOMDIR or a Windows file system. In use, the operator identifies vertebral bodies for analysis for the software to provide a detailed automated annotation of the lateral vertebral margins of the spine on selected vertebrae. The user can then interact with the result to make correction if required.As part of a comprehensive suite of reporting tools, the software calculates the accepted quantitative standard for vertebral assessment using six point morphometry and generates a report in pdf format. The analysis data may also be output as a CSV file or in Windows Excel format. |
|
Hologic C arm at Royal National Orthopaedic Hospital |
|
|
|
|
Vertec’s Keith Lakin is pictured with RNOH Stanmore’s Theatre X-Ray coordinator Michael Kudratt with a Hologic Fluoroscan Insight Mini C-Arm. This system is regularly used by the Foot and Ankle teams in the Theatre suite.Michael is very enthusiastic about the Fluoroscan, “The unit is easily set up and is very user friendly. The Edge Enhancement programme and Last Image capture makes it possible for Surgeons to utilise this unit perioperatively, freeing me to best use my skills and experience elsewhere”Keith adds,”Vertec directs surgeons to a training course which allows them Operator status to legally operate the Fluoroscan.”
|
|
Calypso at the Royal Marsden |
|
|
|
Pictured following the recent handover of a Calypso patient movement tracking system to the Radiotherapy Group at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR) in Sutton, Surrey, are (from left): Vertec sales specialist Nikki Mara, clinical oncologists Professor David Dearnaley and Dr Gerard McVey, physicist Dr Philip Evans, research radiographer Ms Helen McNair and physicists Dr Anthony Kavanagh and Dr Westley Ingram.This installation of Calypso is the first in UK. The system uses a transmitter centred feedback circuit to advise when the target is out of alignment with the treatment beam so that corrective action can be taken. The advantage for this is that dose delivery given to the target is optimised. According to Dr Evans: “Uniquely, the Calypso system uses implanted transponders to measure set-up accuracy during radiotherapy so there is zero radiation dose and set-up accuracy can be measured continuously and more rapidly than alternative systems." The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer treatment, research and education. It is a centre of excellence, and the only NHS Trust to achieve the highest possible ranking in the Healthcare Commission’s Annual Health Check for the fourth year in a row. The ICR is one of the world's leading cancer research organisations and is internationally renowned for the quality of its science. It has been ranked the UK’s top academic research centre, based on the results of the Higher Education Funding Council’s Research Assessment ExerciseTogether, the two organisations form the largest and most comprehensive cancer centre in Europe treating over 40,000 patients every year. Comments Vertec’s Nikki Mara, “We are very pleased that the first Calypso in the UK is here at The Royal Marsden and The Institute of Cancer Research as it is a world centre for clinical excellence in the treatment of cancer patients.” |
|
|
Derby choose Fluoroscan again |
|
|
|
|
Like many health care providers throughout the UK, Royal Derby Hospital has found the Hologic Fluoroscan mini c-arm to be a perfect working partner in the hand and foot operating and outpatients’ environments. The system offers excellent digital imaging and, following a short training course, can be operated by the surgeon. This saves valuable radiographer time, leaving them free to concentrate on the conventional c-arm for procedures that the mini C-arm is not designed for.The Royal Derby already has three Fluoroscan systems, one in the outpatients clinic and two in the Pulvertaft Hand Centre. With the move to the new hospital, a recently acquired fourth machine, like the other three, supplied by Vertec Scientific, is for main theatres covering trauma and elective foot and ankle surgery and some upper limb surgery.Pictured is consultant trauma, orthopaedic and foot and ankle surgeon Mr Stephen Milner with Vertec’s Keith Lakin. Mr Milner comments on the system, “We like the Fluoroscan, not only does is give us good images but because we are trained to operate the system ourselves, we are able to get on with our without involving other hospital staff".
 |
|
Breath Hold Monitoring from Vertec |
|
|
|
|
Developed at the Mayo Clinic, the Breath Hold device, manufactured by Medspira and now marketed in the UK by Vertec Scientific, increases radiologists’ accuracy and confidence during needle biopsy of the lung.During scanning, a simple light display allows the patient to visualise their breathing level and consistently return to it during subsequent biopsies. This consistency in breath-hold positioning is crucial as structures can vary one to six centimeters during normal breathing. Reliable positioning of the target lesion allows for increased rates of nodules being accessed in one needle puncture and a decreased numbers of imaging steps. The decrease in imaging steps during the biopsy reduces the procedure time. Breath Hold provides a faster procedure and also a safer one. Reduced imaging steps means less radiation exposure for both the patient and radiologist. Intermittent imaging has the additional advantage of virtually no radiation exposure for staff as they can leave the room during imaging steps. Increasing the accuracy of the needle biopsy also reduces the post-procedure complications. Confidence in needle placement reduces needle manipulation during the procedure and invasive surgical biopsies can be avoided. Before Breath Hold, nodules considered too small or inaccessible for needle biopsy were either surgically accessed or left to become larger. Comments Tim Anderson of Medspira, “The Mayo Clinic was able to increase their number of needle biopsy cases seen by interventional radiologists by 30-40% because Breath Hold increased their confidence in adequate sampling during needle biopsy.”
|
|
Wythenshawe Hospital, Manchester. The very well respected Womens Health Centre including the Nightingale Breast Screening Unit recently install at Discovery A unit. Shown here with the New Discovery is Dr. Mary Wilson, Radiologist, Mrs. Barbara Coates, Radiographer, David Lee of Hologic and Paul Vaughan of Vertec.
The Royal National Orthopaedic Hospital, Stanmore.
The RNOH are a long-standing DEXA customer; having previously owned a QDR-1000, QDR-1000/W, QDR-4500/W and a Delphi/W. This latest purchase was to replace the ageing 4500 and all data since the first machine has been transferred onto this system. Shown here with the new system are Mrs Anne Johns, Mrs Vishna Shah – radiographers, Dr. Richard Keen, Consultant and Paul Vaughan of Vertec.
St. Peters Hospital, Chertsey.
The Discovery A system replaces an 11 year old QDR-4500/A which had been in constant use. Prior to the QDR-4500/A, St. Peters had owned a QDR-1000/W. Shown here with the new system are (L-R)Dr. Peter Finch, Clinical Director, Ms. Mariann Vijioen, Radiographer, Dr. Liz Bellamy, Consultant Radiologist, Simon Champion, Vertec and Marie Richards, Senior Radiographer. 
Bradford Royal Infirmary, Bradford.
Chosen for it’s ability to provide Supine Lateral Scanning, the Discovery SL at Bradford Royal Infirmary was given the Royal seal of approval by HRH Princess Anne, The Princess Royal, when she formally opened a new DEXA suite. The system was installed last year and has seen more than 3,200 patients from the North Yorkshire area.
Previously, Bradford had a Lunar DPX for many years. Vertec were able to import the old database and cross calibrate the system to ensure continuity of service, despite changing system types.
Shown here is Princess Anne with Christine Kay, Senior Medical Technology Officer.
|
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
|
Page 1 of 2 |
